An IQVIA insider reduced direct holdings by 19% but retains a $5.2 million stake in the company.
An IQVIA Holdings Inc. executive sold 5,000 shares on July 29, 2026, at a weighted average price of $249.16, totaling over $1 million. The sale reduced the executive’s direct holdings by 19%, leaving 20,999 shares valued at $5.2 million based on the July 29 close of $247.56.
IQVIA reported $17.0 billion in revenue and $1.4 billion in net income over the trailing twelve months. The company’s market capitalization stood at $38.8 billion as of July 30, 2026, with shares closing at $237.82.
The company operates in the healthcare sector, providing analytical insights and technology solutions for the life sciences industry through segments including Technology & Analytics Solutions and Research & Development Solutions.